At a young age, Mehran was fascinated with the intricacies of the brain and how it functions. Originally intending to take the path of prosthetics and surgery, he ultimately realized that there was a need for non-invasive brain tools and neuromodulation, allowing patients to experience health improvement without medication or surgery.
Now, Mehran is a biomedical engineer with advanced entrepreneurial skills that led him to be named as one of Invest Ottawa’s National Capital Region’s 100 RisingStar CEOs in 2012. In 2014, they designated him the title of Honorary RisingStar CEO for the advancement of his company NeuroQore, founded in 2012 with long-time colleague Adrian D.C. Chan. He has created partnerships with investors, universities, and medical facilities that have helped him, and his partners, raise significant capital funds. He remains as effective in a business setting as he does in practice and research.
As a hands-on CEO, Mehran aims for giant leaps and breakthroughs in the growth of his research, which centers in magnetic neuromodulation for the benefit of improving a patient’s life. This provides a high reward, both within the scope of the company as well as patient care. Creating his own company has allowed him to execute his own visions and ideas while experiencing humility and immense satisfaction as he is able to witness patients move into remission after having suffered from devastating chronic disorders.
Building an enterprise that promises to change the landscape of brain health remains a large part of why Mehran co-founded NeuroQore. NeuroQore offers a novel form of repetitive transcranial magnetic stimulation (rTMS) with an improved pulse, with personalized targeting, an accelerated protocol with onset effects within hours, and post-treatment brain assessments. As CEO, Mehran works alongside a passionate and diverse team to grow the company and provide affordable health care for more patients.
Did you know?
While it might look like a plant-based food company, NotCo is in the data and AI business—and aims to disrupt R&D in many industries that use animal and plant ingredients.
Gilberto Loureiro grew up inspecting fabrics in a Portuguese textile factory. With Smartex, he and co-founders Antonio Rocha and Paulo Ribeiro are eliminating textile defects—and their enormous cost both to manufacturers and the environment.
Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.
To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.
In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.
In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.
It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.
Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.